High Growth Tech Stocks To Watch In The US April 2025
Name
Revenue Growth
Earnings Growth
Growth Rating
Super Micro Computer
20.29%
29.79%
★★★★★★
TG Therapeutics
26.06%
37.39%
★★★★★★
Travere Therapeutics
28.65%
66.06%
★★★★★★
Arcutis Biotherapeutics
26.11%
58.46%
★★★★★★
Alkami Technology
20.46%
85.16%
★★★★★★
Clene
62.08%
64.01%
★★★★★★
Alnylam Pharmaceuticals
23.08%
58.88%
★★★★★★
AVITA Medical
27.81%
55.17%
★★★★★★
Lumentum Holdings
21.34%
120.49%
★★★★★★
Ascendis Pharma
32.78%
59.70%
★★★★★★
Click here to see the full list of 234 stocks from our US High Growth Tech and AI Stocks screener.
Let's explore several standout options from the results in the screener.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Okta, Inc. is a global identity management company that provides secure access solutions for enterprises, with a market capitalization of approximately $17.07 billion.
Operations: The company generates revenue primarily from its Internet Software & Services segment, totaling $2.61 billion.
Okta's recent pivot towards enhancing security in generative AI applications marks a strategic expansion in high-growth tech sectors. By introducing Auth for GenAI, Okta addresses critical gaps in AI-driven application security, catering to the burgeoning demand for robust identity verification systems. This move not only diversifies Okta's product offerings but also positions it favorably within an industry shifting rapidly towards AI integration. Financially, Okta has turned a corner with its latest annual report showing a swing to a net income of $28 million from a previous net loss of $355 million, reflecting significant operational improvements and potential for sustained growth.
Delve into the full analysis health report here for a deeper understanding of Okta.
Understand Okta's track record by examining our Past report.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Kyndryl Holdings, Inc. is a global technology services company specializing in IT infrastructure services, with a market cap of approximately $7.22 billion.
Operations: The company generates revenue primarily from its IT infrastructure services across various regions, with the United States contributing $3.90 billion and Principal Markets adding $5.63 billion to its revenue streams.
Kyndryl Holdings, recently profitable, is navigating the high-growth tech landscape with strategic initiatives in AI and data security. The company's launch of Kyndryl Consult Data Security Posture Management with Microsoft Purview underscores its commitment to enhancing data protection capabilities across hybrid environments. This move, coupled with a suite of AI private cloud services developed in collaboration with NVIDIA, positions Kyndryl to capitalize on enterprise-grade AI solutions demand. Despite modest revenue growth at 1.1% annually, Kyndryl's earnings are expected to surge by 47.8% per year, showcasing a significant turnaround in profitability and operational efficiency.
Unlock comprehensive insights into our analysis of Kyndryl Holdings stock in this health report.
Assess Kyndryl Holdings' past performance with our detailed historical performance reports.
Simply Wall St Growth Rating: ★★★★★☆
Overview: TKO Group Holdings, Inc. is a sports and entertainment company with a market capitalization of approximately $25.85 billion.
Operations: TKO Group Holdings generates revenue primarily through its UFC and WWE segments, contributing approximately $1.41 billion and $1.40 billion, respectively. The company operates within the sports and entertainment industry, leveraging these major brands to drive its financial performance.
TKO Group Holdings has demonstrated a robust trajectory in the high-growth tech sector, notably with its recent earnings turnaround and strategic licensing expansions. In 2024, the company not only reversed its net losses, posting a net income of $31 million from a previous loss but also increased its sales to $642.2 million from $614 million year-over-year. This financial revitalization is underscored by an aggressive revenue target of up to $3 billion for 2025, reflecting an annual growth rate of 16.8%. Additionally, TKO's strategic move to extend its licensing agreement with WWE and Mattel ensures continued penetration into diverse global markets, leveraging popular culture for sustained growth. This blend of financial health and strategic partnerships positions TKO well within the competitive tech landscape.
Navigate through the intricacies of TKO Group Holdings with our comprehensive health report here.
Learn about TKO Group Holdings' historical performance.
Dive into all 234 of the US High Growth Tech and AI Stocks we have identified here.
Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.
Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqGS:OKTA NYSE:KD and NYSE:TKO.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 hours ago
- Yahoo
Top Growth Stocks With High Insider Ownership July 2025
The United States market has shown positive momentum recently, with a 2.1% increase over the last week and a 14% rise in the past year, as all sectors have gained ground. In light of these strong market conditions and an anticipated annual earnings growth of 15%, stocks with high insider ownership can be particularly appealing as they often indicate confidence from those closest to the company's operations and potential for sustained growth. Name Insider Ownership Earnings Growth Zapp Electric Vehicles Group (ZAPP.F) 16.1% 170.8% Super Micro Computer (SMCI) 13.9% 39.1% Ryan Specialty Holdings (RYAN) 15.6% 95.3% Prairie Operating (PROP) 34.6% 92.4% FTC Solar (FTCI) 28.3% 62.5% Enovix (ENVX) 12.1% 58.4% Credo Technology Group Holding (CRDO) 11.9% 45% Atour Lifestyle Holdings (ATAT) 21.8% 23.7% Astera Labs (ALAB) 13.1% 44.4% ARS Pharmaceuticals (SPRY) 14.3% 63.1% Click here to see the full list of 188 stocks from our Fast Growing US Companies With High Insider Ownership screener. Underneath we present a selection of stocks filtered out by our screen. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Astrana Health, Inc. is a healthcare management company offering medical care services in the United States with a market cap of approximately $1.26 billion. Operations: Astrana Health generates revenue through its segments: Care Delivery ($139.34 million), Care Partners ($2.17 billion), and Care Enablement ($161.74 million). Insider Ownership: 12.5% Revenue Growth Forecast: 15.1% p.a. Astrana Health's revenue is forecast to grow at 15.1% annually, outpacing the US market average, while earnings are expected to rise significantly at 30.8% per year. Despite recent index exclusions and a drop in profit margins, the company remains undervalued by 81.7%. Recent leadership changes aim to bolster its AI-enabled care platform as it scales nationally. A completed share buyback program signals confidence amidst these strategic shifts and financial challenges. Click to explore a detailed breakdown of our findings in Astrana Health's earnings growth report. Insights from our recent valuation report point to the potential undervaluation of Astrana Health shares in the market. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Youdao, Inc. is an internet technology company offering online services in content, community, communication, and commerce sectors in China with a market cap of approximately $1.03 billion. Operations: The company's revenue is primarily derived from Learning Services (CN¥2.63 billion), Online Marketing Services (CN¥1.99 billion), and Smart Devices (CN¥912.97 million). Insider Ownership: 20.4% Revenue Growth Forecast: 11.3% p.a. Youdao's revenue is projected to grow at 11.3% annually, surpassing the US market rate, while its earnings are expected to rise significantly at 35.7% per year. The company recently became profitable but faces challenges with negative shareholders' equity and debt coverage by operating cash flow. Despite no recent insider trading activity, Youdao completed a substantial share buyback of 6.19%, reflecting confidence in its growth trajectory amidst financial hurdles. Delve into the full analysis future growth report here for a deeper understanding of Youdao. Our valuation report here indicates Youdao may be overvalued. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Perfect Corp. is an artificial intelligence software as a service company offering AI and AR-powered solutions for the beauty, fashion, and skincare industries globally, with a market cap of $257.68 million. Operations: The company's revenue primarily comes from its Internet Software & Services segment, generating $61.93 million. Insider Ownership: 23% Revenue Growth Forecast: 12.9% p.a. Perfect Corp. is poised for growth with forecasted annual earnings increases of 22.1%, outpacing the US market. Recent strategic partnerships, like its integration with NVIDIA, enhance its AI and AR capabilities, transforming consumer experiences in beauty and fashion through virtual try-ons and AI-driven recommendations. Despite limited insider trading data, Perfect Corp.'s innovative solutions are expected to drive revenue growth at 12.9% annually, supported by recent product launches that address online shopping challenges effectively. Dive into the specifics of Perfect here with our thorough growth forecast report. Our comprehensive valuation report raises the possibility that Perfect is priced higher than what may be justified by its financials. Access the full spectrum of 188 Fast Growing US Companies With High Insider Ownership by clicking on this link. Contemplating Other Strategies? Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 24 best rare earth metal stocks of the very few that mine this essential strategic resource. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include ASTH DAO and PERF. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Errore nel recupero dei dati Effettua l'accesso per consultare il tuo portafoglio Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati
Yahoo
9 hours ago
- Yahoo
High Growth Tech Stocks In The US To Watch This July 2025
The United States market has experienced a 2.1% increase over the past week and is up 14% over the last year, with earnings projected to grow by 15% annually. In this environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability to capitalize on these favorable conditions. Name Revenue Growth Earnings Growth Growth Rating Super Micro Computer 24.71% 39.09% ★★★★★★ Circle Internet Group 32.27% 61.44% ★★★★★★ Mereo BioPharma Group 50.84% 58.22% ★★★★★★ Ardelyx 21.02% 61.29% ★★★★★★ TG Therapeutics 26.46% 38.75% ★★★★★★ AVITA Medical 27.42% 61.04% ★★★★★★ Alkami Technology 20.53% 76.67% ★★★★★★ Alnylam Pharmaceuticals 23.72% 59.95% ★★★★★★ Ascendis Pharma 35.07% 59.92% ★★★★★★ Lumentum Holdings 23.02% 103.97% ★★★★★★ Click here to see the full list of 217 stocks from our US High Growth Tech and AI Stocks screener. Underneath we present a selection of stocks filtered out by our screen. Simply Wall St Growth Rating: ★★★★★☆ Overview: Amicus Therapeutics, Inc. is a biotechnology company dedicated to discovering, developing, and delivering novel medicines for rare diseases globally, with a market capitalization of approximately $1.88 billion. Operations: FOLD focuses on the discovery, development, and commercialization of advanced therapies for rare diseases, generating $543.14 million in revenue. Amicus Therapeutics, despite being unprofitable, shows promising growth prospects with a revenue increase forecasted at 17.7% annually, outpacing the US market's 8.7%. The company's recent approval in Japan for its innovative two-component therapy for Pompe disease underscores its commitment to expanding global access to treatment. This strategic move, coupled with a significant reduction in net loss from $48.42 million to $21.69 million year-over-year and an anticipated profitability within three years, positions Amicus as a potential key player in biotech innovation and market expansion. Click here and access our complete health analysis report to understand the dynamics of Amicus Therapeutics. Examine Amicus Therapeutics' past performance report to understand how it has performed in the past. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Okta, Inc. operates as an identity partner both in the United States and internationally, with a market cap of $17.35 billion. Operations: Okta generates revenue primarily from its Internet Software & Services segment, amounting to $2.68 billion. Okta, recently profitable, is navigating the high-growth tech landscape with innovations like its Cross App Access protocol, enhancing AI agent security across enterprise applications. This move reflects a strategic pivot to address the complexities of modern cybersecurity, especially as enterprises integrate more autonomous AI tools. With a robust 25% expected annual earnings growth and recent revenue hitting $688 million—a significant leap from last year—the company is poised for continued expansion. These developments come alongside Okta's active participation in major industry conferences, underscoring its commitment to shaping future tech standards and practices. Get an in-depth perspective on Okta's performance by reading our health report here. Learn about Okta's historical performance. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company specializing in RNA-targeted therapeutics and gene therapies for rare diseases, with a market cap of approximately $1.79 billion. Operations: Sarepta Therapeutics generates revenue primarily from discovering, developing, manufacturing, and delivering therapies for rare diseases, amounting to $2.23 billion. The company's operations focus on RNA-targeted therapeutics and gene therapies. Sarepta Therapeutics, despite its unprofitable status and a projected revenue decline of 0.6% annually, is navigating the high-growth biotech landscape with significant strategic moves. Recently added to multiple Russell indexes, the company is poised to enhance its market visibility. Sarepta's commitment to innovation is underscored by its recent safety updates and regulatory engagements concerning ELEVIDYS, its gene therapy for Duchenne muscular dystrophy. This focus on advancing gene therapies reflects a broader industry trend towards targeted, personalized medicine—a sector that continues to attract significant investment and research interest. Dive into the specifics of Sarepta Therapeutics here with our thorough health report. Evaluate Sarepta Therapeutics' historical performance by accessing our past performance report. Click through to start exploring the rest of the 214 US High Growth Tech and AI Stocks now. Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up. Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include FOLD OKTA and SRPT. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
12 hours ago
- Yahoo
Super Micro Computer's BigTwin Server Achieves Industry-First Intel Immersion Cooling Certification
Super Micro Computer Inc. (NASDAQ:SMCI) is one of the best NASDAQ growth stocks to buy for the next 3 years. On July 1, Super Micro Computer announced an industry-first: its BigTwin Multi-Node Server, which is equipped with 4th and 5th Gen Intel Xeon Scalable Processors, has been certified by Intel for immersion cooling. This certification follows quality and performance testing of the Supermicro server in combination with a specified liquid and immersion tank. Additionally, the Supermicro BigTwin system successfully passed thorough testing aligned with the Open Compute Project/OCP specification for material compatibility in immersion cooling. Supermicro's immersion-certified servers aim to lower Power Usage Effectiveness/PUE by eliminating the need for traditional air-based cooling. By submerging high-density and fanless servers directly in dielectric fluid, heat dissipates more efficiently than with air, which reduces the energy required for cooling units like CRAC and CRAH. A team of technicians in a server room, testing and managing the newest server solutions. This approach allows for denser compute configurations without increasing thermal load and reduces overall IT equipment power consumption by removing internal server fans. Data centers using Supermicro immersion servers are capable of achieving PUE values near 1.05 or lower. The certified system specifically tested was the BigTwin SuperServer SYS-221BT-HNTR. Super Micro Computer Inc. (NASDAQ:SMCI) develops and sells high-performance server and storage solutions based on modular and open architecture in the US, Europe, Asia, and internationally. While we acknowledge the potential of SMCI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey.
